Paragon Genomics NGS Panel Captures New SARS-CoV-2 Mutations
Share Article
Several reports of the new SARS-CoV-2 mutations on the spike protein have been detected around the world, including the United Kingdom, South Africa, and the United States. Officials in both the United Kingdom and South Africa have said that the mutations were driving the countries’ resurgence of the disease, with higher numbers of confirmed cases, hospitalizations, and deaths. To date, the FDA has identified three molecular assays whose performance could be impacted by SARS-CoV-2 genetic variants, and is suggesting that laboratories with access to quick-turnaround whole-genome sequencing services should consider further characterizing the specimen with genetic sequencing. The SARS-CoV-2 FLEX Panel by Paragon Genomics, Inc., is a full genome sequencing-based Coronavirus assay for detection, research and surveillance, with unique design elements that allow for more robust and confident variant calling, even